-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MScO0Vsi0rIwPZJmCU5AS1tyyfUdahDNZcVSYBFgRJhji4170zWCFv+bT6fF/YFq 7+jj5ZPhjDa1T64db3qMHw== 0000064670-07-000101.txt : 20071031 0000064670-07-000101.hdr.sgml : 20071030 20071031133824 ACCESSION NUMBER: 0000064670-07-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071029 FILED AS OF DATE: 20071031 DATE AS OF CHANGE: 20071031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCormick Carol CENTRAL INDEX KEY: 0001397538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 071202145 BUSINESS ADDRESS: BUSINESS PHONE: 763-514-4000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC310 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2007-10-29 0000064670 MEDTRONIC INC MDT 0001397538 McCormick Carol MEDTRONIC INC 710 MEDTRONIC PKWY MINNEAPOLIS MN 55432 0 1 0 0 Sr VP Human Resources Common Stock 2007-10-29 4 A 0 5234 0 A 8727.719 D Common Stock 1101.383 I by 401k Common Stock 4483.228 I by ESOP Stock Options (Right to buy) 47.77 2007-10-29 4 A 0 23028 0 A 2008-10-29 2017-10-29 Common Stock 23028 23028 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. The restrictions on these shares shall lapse 100% on the third anniversay of the grant date if the Company's cumulative earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2010 equals or exceeds a 9% compound annual growth rate, as determined by the Compensation Committee. James N. Spolar, Attorney-in-fact 2007-10-31 -----END PRIVACY-ENHANCED MESSAGE-----